Literature DB >> 9560298

Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix.

W Kafienah1, D Brömme, D J Buttle, L J Croucher, A P Hollander.   

Abstract

Cathepsin K (EC 3.4.22.38) is a recently described enzyme that has been shown to cleave type I collagen in its triple helix. The aim of this study was to determine if it also cleaves type II collagen in the triple helix and to identify the helical cleavage site(s) in types I and II collagens. Soluble human and bovine type II collagen, and rat type I collagen, were incubated with cathepsin K before the reaction was stopped with trans-epoxysuccinyl-l-leucylamido-(4-guanidino)butane (E-64). Analysis by SDS/PAGE of the collagen digests showed that optimal activity of cathepsin K against native type II collagen was between pH 5.0 and 5.5 and against denatured collagen between pH 4.0 and 7.0. The enzyme cleaved telopeptides as well as the alpha1(II) chains, generating multiple fragments in the range 90-120 kDa. The collagenolytic activity was not due to a contaminating metalloenzyme or serine proteinase as it was not inhibited by 1,10-phenanthroline, EDTA or 3,4-dichloroisocoumarin. Western blotting with anti-peptide antibodies to different regions of the alpha1(II) chain suggested that cathepsin K cleaved native alpha1(II) chains in the N-terminal region of the helical domain rather than at the well-defined collagenase cleavage site. This was confirmed by N-terminal sequencing of one of the fragments, revealing cleavage at a Gly-Lys bond, 58 residues from the N-terminus of the helical domain. By using a similar approach, cathepsin K was found to cleave native type I collagen close to the N-terminus of its triple helix. These results indicate that cathepsin K could have a role in the turnover of type II collagen, as well as type I collagen.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9560298      PMCID: PMC1219411          DOI: 10.1042/bj3310727

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  A rapid and reproducible assay for collagenase using [1-14C]acetylated collagen.

Authors:  T E Cawston; A J Barrett
Journal:  Anal Biochem       Date:  1979-11-01       Impact factor: 3.365

2.  Isolation and characterization of a peptide containing the site of cleavage of the chick skin collagen alpha 1[I] chain by animal collagenases.

Authors:  J H Highberger; C Corbett; J Gross
Journal:  Biochem Biophys Res Commun       Date:  1979-07-12       Impact factor: 3.575

Review 3.  Plasminogen activation and regulation of pericellular proteolysis.

Authors:  O Saksela
Journal:  Biochim Biophys Acta       Date:  1985-11-12

4.  Catabolism and turnover of collagens: collagenases.

Authors:  H Birkedal-Hansen
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  The degradation of articular collagen by neutrophil proteinases.

Authors:  P M Starkey; A J Barrett; M C Burleigh
Journal:  Biochim Biophys Acta       Date:  1977-08-11

Review 6.  The intracellular neutral SH-dependent protease associated with inflammatory reactions.

Authors:  H Hayashi
Journal:  Int Rev Cytol       Date:  1975

7.  Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.

Authors:  M S Hibbs; K A Hasty; J M Seyer; A H Kang; C L Mainardi
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

8.  Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes.

Authors:  S Garbisa; M Ballin; D Daga-Gordini; G Fastelli; M Naturale; A Negro; G Semenzato; L A Liotta
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

9.  Action of rat liver cathepsin L on collagen and other substrates.

Authors:  H Kirschke; A A Kembhavi; P Bohley; A J Barrett
Journal:  Biochem J       Date:  1982-02-01       Impact factor: 3.857

10.  The gelatinolytic activity of human skin fibroblast collagenase.

Authors:  H G Welgus; J J Jeffrey; G P Stricklin; A Z Eisen
Journal:  J Biol Chem       Date:  1982-10-10       Impact factor: 5.157

View more
  72 in total

Review 1.  Who are the proteolytic culprits in vascular disease?

Authors:  W C Parks
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  A putative role for cathepsin K in degradation of AA and AL amyloidosis.

Authors:  C Röcken; B Stix; D Brömme; S Ansorge; A Roessner; F Bühling
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Current research on pycnodysostosis.

Authors:  Serap Turan
Journal:  Intractable Rare Dis Res       Date:  2014-08

4.  Influence of cell printing on biological characters of chondrocytes.

Authors:  Miao Qu; Xiaoyan Gao; Yikang Hou; Congcong Shen; Yourong Xu; Ming Zhu; Hengjian Wang; Haisong Xu; Gang Chai; Yan Zhang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K.

Authors:  A F Schilling; C Mülhausen; W Lehmann; R Santer; T Schinke; J M Rueger; M Amling
Journal:  Osteoporos Int       Date:  2007-01-06       Impact factor: 4.507

6.  Release of prostaglandin E(1) from N-(2-hydroxypropyl)methacrylamide copolymer conjugates by bone cells.

Authors:  Huaizhong Pan; Jihua Liu; Yuanyi Dong; Monika Sima; Pavla Kopecková; Maria Luisa Brandi; Jindrich Kopecek
Journal:  Macromol Biosci       Date:  2008-07-07       Impact factor: 4.979

7.  Potential role of cathepsin K in the pathophysiology of mucopolysaccharidoses.

Authors:  Susan Wilson; Dieter Brömme
Journal:  J Pediatr Rehabil Med       Date:  2010

Review 8.  Targeting subchondral bone for treating osteoarthritis: what is the evidence?

Authors:  Steeve Kwan Tat; Daniel Lajeunesse; Jean-Pierre Pelletier; Johanne Martel-Pelletier
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-02       Impact factor: 4.098

9.  Probing cathepsin K activity with a selective substrate spanning its active site.

Authors:  Fabien Lecaille; Enrico Weidauer; Maria A Juliano; Dieter Brömme; Gilles Lalmanach
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

10.  S3 to S3' subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates.

Authors:  Marcio F M Alves; Luciano Puzer; Simone S Cotrin; Maria Aparecida Juliano; Luiz Juliano; Dieter Brömme; Adriana K Carmona
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.